PCG
Prosperity Consulting Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.78M | Sell |
25,765
-642
| -2% | -$119K | 0.35% | 67 |
|
|
2025
Q1 | $5.53M | Sell |
26,407
-207
| -0.8% | -$43.4K | 0.43% | 53 |
|
|
2024
Q4 | $4.73M | Buy |
26,614
+187
| +0.7% | +$33.2K | 0.36% | 68 |
|
|
2024
Q3 | $5.22M | Buy |
26,427
+2,651
| +11% | +$524K | 0.41% | 60 |
|
|
2024
Q2 | $4.08M | Sell |
23,776
-6,498
| -21% | -$1.11M | 0.55% | 48 |
|
|
2024
Q1 | $5.51M | Buy |
30,274
+21,304
| +238% | +$3.88M | 0.69% | 36 |
|
|
2023
Q4 | $1.39M | Buy |
8,970
+981
| +12% | +$152K | 0.47% | 49 |
|
|
2023
Q3 | $1.19M | Buy |
7,989
+5,978
| +297% | +$891K | 0.55% | 46 |
|
|
2023
Q2 | $271K | Buy |
2,011
+11
| +0.6% | +$1.48K | 0.17% | 90 |
|
|
2023
Q1 | $319K | Sell |
2,000
-59
| -3% | -$9.4K | 0.2% | 84 |
|
|
2022
Q4 | $333K | Buy |
+2,059
| New | +$333K | 0.22% | 78 |
|
|
2022
Q3 | – | Sell |
-1,862
| Closed | -$285K | – | 97 |
|
|
2022
Q2 | $285K | Sell |
1,862
-18
| -1% | -$2.76K | 0.25% | 70 |
|
|
2022
Q1 | $305K | Sell |
1,880
-1
| -0.1% | -$162 | 0.23% | 76 |
|
|
2021
Q4 | $261K | Buy |
+1,881
| New | +$261K | 0.2% | 86 |
|